RHOA is activated upon binding of chemokines, cytokines, and growth factors [51,52] and its product is one of the major inducers of lung inflammation and acute lung injury, as it inhibits apoptosis and promotes the proliferation of lung cancer cells [53,54]. Here, RHOA is linked to lung cancer.